SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lyka Labs informs about scheme of amalgamation

26 Oct 2024 Evaluate
Lyka Labs has informed that in furtherance to Outcome of the Board Meeting dated 11th October, 2024, wherein the Board of Directors at its Meeting held on 11th October, 2024 has, approved the filing of fresh application of Scheme of Amalgamation between Lyka Exports (the Transferor Company) and Lyka Labs (the Transferee Company) and their respective Shareholders with the Hon’ble National Company Law Tribunal Division Bench, Court - I, Ahmedabad (the NCLT) terms of the Order dated 24th September, 2024 passed by the NCLT. Pursuant to the aforesaid approval for the filing of fresh application, a Joint application by Lyka Exports and Lyka Labs for the Scheme of Amalgamation has been filed on 25th October 2024 with the NCLT.

The above information is a part of company’s filings submitted to BSE.

Lyka Labs Share Price

58.16 0.56 (0.97%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×